3Houlden R, Ross S, Harris S, et al. Treatment satisfaction and quality of life using an early insulinization strategy with in- sulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes: The Canadian INSIGHT study[J].Diabetes Res Clin Pract,2007,78(2):254-258.
4Rosen stock J,Vico M,Wei L,et al. Effects of Dapagli- flozin, an SGLT2 inhibitor, on HbA lc,body weight, and hy- poglycemia risk in patients with type 2 diabetes inade- quately controlled on Pioglitazone monotherapy[J]. Diabetes Care,2012,35(7):1473-1478.
5Haskell WL, Lee IM, Pate RR,et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association[J].Am J Clin Nutr,2006,83(2):260-274.
